Gujarat Themis Biosyn Ltd

🔬 Gujarat Themis Biosyn Boosts Fermentation Capacity to 990 KL, Launches Rifamycin-S & Rifamycin-O

- Fermentation capacity increased from 450 KL to 990 KL.

- Commercial production of Rifamycin-S and Rifamycin-O commenced on October 18, 2025.

- Expansion of Fermentation Block at Vapi, Gujarat facility completed.

- Strengthens manufacturing capabilities for multiple fermentation products.

- Company aims to capitalize on growth opportunities in the fermentation segment.